Optimizing Roux-en-Y gastric bypass: results of the BPG-1 randomized trial on limb length configuration.
Débora Acín Gándara, Fernando Pereira Pérez, Juan José Arroyo Martín et al.
✦ AI-curated · Sources linked
In 30 seconds
The BPG-1 randomized trial evaluated the impact of biliopancreatic limb (BPL) length on weight loss and disease remission in 98 adults undergoing Roux-en-Y gastric bypass. Results showed that a longer BPL (150 cm) led to greater excess weight loss at 24 months (89% vs 78%, P = .02) and total weight loss (39% vs 33%, P = .0002), with improved type 2 diabetes remission at 12 months (90% vs 64%, P = .045).
Key findings
- At 24 months, excess weight loss was 89% for the long BPL group compared to 78% for the short BPL group (P = .02).
- Total weight loss at 24 months was 39% for the long BPL group versus 33% for the short BPL group (P = .0002).
- Complete remission of type 2 diabetes at 12 months was 90% in the long BPL group compared to 64% in the short BPL group (P = .045).
Why it matters
Understanding the optimal configuration of limb lengths in Roux-en-Y gastric bypass can enhance weight loss outcomes and improve remission rates for obesity-related diseases, particularly type 2 diabetes, which is crucial for patient management and long-term health.